Stock comparison

LLYvsVXUS

Eli Lilly and CovsVanguard Total International Stock ETF. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

LLY

Eli Lilly and Co

$917.65

-12.96%

Pharmaceuticals$884.0BNYSE

VXUS

Vanguard Total International Stock ETF

$81.72

+8.08%

International — Developed$636.7BNASDAQ

60-day price, rebased to 100

LLY -11.52% · VXUS +1.21%

Round-by-round

LLY 2·VXUS 1· 3ties

Tie

Valuation upside

-70.70% vs — to DCF fair value

Tie

Balance-sheet strength

Altman Z 8.14 vs —

EdgeLLY

Fundamental quality

Piotroski 8.00 vs 0.00 (of 9)

Tie

Growth + margins

Rule-of-40 53.90 vs —

EdgeVXUS

60-day momentum

-11.52% vs +1.21% price return

EdgeLLY

Market-cap liquidity

$884.0B vs $636.7B

Verdict

Across6categories,LLYtakes the edge with2wins to1 (and 3 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onLLYorVXUS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.